InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Sukhtian Ghiath M., Director. Director active across 1 companies, notably Outlook Therapeutics, Inc.. Aggregated, 4 disclosures have been logged. Total volume traded: €35.4m. The latest transaction was filed on 1 February 2022 — J. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations4 total
€3m2,500,000 shares@ €1.113110.09% mcap13.6% of flow
Common Stock
SEC:0000947871-22-000124·
€3m2,500,000 shares@ €1.113110.09% mcap6.8% of flow
Common Stock
SEC:0000947871-22-000124:0·
€18m16,000,000 shares@ €1.106964.24% mcap86.4% of flow
Common Stock
SEC:0000947871-21-001250·
Ideal exit: 26 Aug 2022 (T+270)
€18m16,000,000 shares@ €1.106964.24% mcap43.2% of flow
Common Stock
SEC:0000947871-21-001250:0·
Ideal exit: 26 Aug 2022 (T+270)
4 of 4 declarations
About Sukhtian Ghiath M.
Ghiath M. Sukhtian is a Director at Outlook Therapeutics, Inc. In this role, he participates in the governance and strategy of the company. His experience is valuable for the development of Outlook Therapeutics.
